Multilayer-coated liquid crystalline nanoparticles for effective sorafenib delivery to hepatocellular carcinoma

ACS Applied Materials and Interfaces

Volumn 7, Issue 36, 2015, Pages 20360-20368

  Thapa, Raj Kumar ^a   Choi, Ju Yeon ^a   Poudel, Bijay K ^a   Hiep, Tran Tuan ^a   Pathak, Shiva ^a   Gupta, Biki ^a   Choi, Han Gon ^b   Yong, Chul Soon ^a   Kim, Jong Oh ^a  

^a Yeungnam University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

hepatocellular carcinoma; layer by layer; liquid crystalline nanoparticles; multilayer; sorafenib

Indexed keywords

AMPHIBIOUS VEHICLES; ATOMIC FORCE MICROSCOPY; CRYSTALLINE MATERIALS; DRUG PRODUCTS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MULTILAYERS; NANOPARTICLES; ONCOGENIC VIRUSES; PARTICLE SIZE; POLYDISPERSITY; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

ACIDIC MICROENVIRONMENT; DRUG DELIVERY VEHICLES; FOOD AND DRUG ADMINISTRATION; HEPATOCELLULAR CARCINOMA; LAYER BY LAYER; LIQUID CRYSTALLINE NANOPARTICLES; SELF ASSEMBLED STRUCTURES; SORAFENIB;

LIQUIDS;

CARBANILAMIDE DERIVATIVE; DRUG CARRIER; NANOPARTICLE; NICOTINAMIDE; POLYMER; SORAFENIB;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; ATOMIC FORCE MICROSCOPY; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFECTS; DRUG RELEASE; ERYTHROCYTE; HEMOLYSIS; HEPG2 CELL LINE; HUMAN; INFRARED SPECTROSCOPY; LIQUID CRYSTAL; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; PH; RAT; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; CALORIMETRY, DIFFERENTIAL SCANNING; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; DRUG CARRIERS; DRUG LIBERATION; ERYTHROCYTES; HEMOLYSIS; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIQUID CRYSTALS; LIVER NEOPLASMS; MALE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NIACINAMIDE; PHENYLUREA COMPOUNDS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84941778665     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.5b06203     Document Type: Article

References (31)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global Cancer Statistics Ca-Cancer J. Clin. 2011, 61, 69-90 10.3322/caac.20107
2. El-Serag, H. B. Hepatocellular Carcinoma N. Engl. J. Med. 2011, 365, 1118-1127 10.1056/NEJMra1001683
3. Marotta, F.; Vangieri, B.; Cecere, A.; Gattoni, A. The Pathogenesis of Hepatocellular Carcinoma is Multifactorial Event. Novel Immunological Treatment in Prospect Clin. Ter. 2004, 155 (5) 187-199
4. Calvisi, D. F.; Ladu, S.; Gorden, A.; Farina, M.; Conner, E. A.; Lee, J. S.; Factor, V. M.; Thorgeirsson, S. S. Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC Gastroenterology 2006, 130 (4) 1117-1128 10.1053/j.gastro.2006.01.006
5. Avila, M. A.; Berasain, C.; Sangro, B.; Prieto, J. New Therapies for Hepatocellular Carcinoma Oncogene 2006, 25 (27) 3866-3884 10.1038/sj.onc.1209550
6. Xie, B.; Wang, D. H.; Spechler, S. J. Sorafenib for Treatment of Hepatocellular Carcinoma: A Systemic Review Dig. Dis. Sci. 2012, 57 (5) 1122-1129 10.1007/s10620-012-2136-1
7. Kane, R. C.; Farrell, A. T.; Madabushi, R.; Booth, B.; Chattopadhyay, S.; Sridhara, R.; Justice, R.; Pazdur, R. Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma Oncologist 2009, 14 (1) 95-100 10.1634/theoncologist.2008-0185
8. Wang, X. Q.; Fan, J. M.; Liu, Y. O.; Zhao, B.; Jia, Z. R.; Zhang, Q. Bioavailability and Pharmacokinetics of Sorafenib Suspension, Nanoparticles and Nanomatrix for Oral Administration to Rat Int. J. Pharm. 2011, 419, 339-346 10.1016/j.ijpharm.2011.08.003
9. Zhang, J. Y.; He, B.; Qu, W.; Cui, Z.; Wang, Y. B.; Zhang, H.; Wang, J. C.; Zhang, Q. Preparation of the Albumin Nanoparticle System Loaded with Both Paclitaxel and Sorafenib and its Evaluation In vitro and In vivo J. Microencapsulation 2011, 28, 528-536 10.3109/02652048.2011.590614
10. Swarnakar, N. K.; Thanki, K.; Jain, S. Bicontinuous Cubic Liquid Crystalline Nanoparticles for Oral Delivery of Doxorubicin: Implications on Bioavailability, Therapeutic Efficacy, and Cardiotoxicity Pharm. Res. 2014, 31 (5) 1219-1238 10.1007/s11095-013-1244-8
11. Yang, D.; Armitage, B.; Marder, S. R. Cubic Liquid-crystalline Nanoparticles Angew. Chem., Int. Ed. 2004, 43 (34) 4402-4409 10.1002/anie.200301683
12. Barauskas, J.; Johnsson, M.; Tiberg, F. Self-assembled Lipid Superstructures: Beyond Vesicles and Liposomes Nano Lett. 2005, 5 (8) 1615 10.1021/nl050678i
13. Barauskas, J.; Cervin, C.; Jankunec, M.; Spandyreva, M.; Ribokaite, K.; Tiberg, F.; Johnsson, M. Interactions of Lipid-Based Liquid Crystalline Nanoparticles with Model and Cell Membranes Int. J. Pharm. 2010, 391 (1-2) 284-291 10.1016/j.ijpharm.2010.03.016
14. Gabizon, A.; Shmeeda, H.; Zalipsky, S. Pros and Cons of the Liposome Platform in Cancer Drug Targeting J. Liposome Res. 2006, 16, 175-183 10.1080/08982100600848769
15. Allen, T. M.; Mehra, T.; Hansen, C.; Chin, Y. C. Stealth Liposomes: An Improved Sustained Release System for 1-beta-D-arabinofuranosylcytosine Cancer Res. 1992, 52 (9) 2431-2439
16. Thapa, R. K.; Yoo, B. K. Evaluation of the Effect of Tacrolimus-loaded Liquid Crystalline Nanoparticles on Psoriasis-like Skin Inflammation J. Dermatol. Treat. 2014, 25 (1) 22-25 10.3109/09546634.2012.755250
17. Thapa, R. K.; Baskaran, R.; Madheswaran, T.; Kim, J. O.; Yong, C. S.; Yoo, B. K. Preparation, Characterization, and Release Study of Tacrolimus-loaded Liquid Crystalline Nanoparticles J. Dispersion Sci. Technol. 2013, 34 (1) 72-77 10.1080/01932691.2011.648462
18. Ramasamy, T.; Haidar, Z. S.; Tran, T. H.; Choi, J. Y.; Jeong, J. H.; Shin, B. S.; Choi, H. G.; Yong, C. S.; Kim, J. O. Layer-by-layer Assembly of Liposomal Nanoparticles with PEGylated Polyelectrolytes Enhances Systemic Delivery of Multiple Anticancer Drugs Acta Biomater. 2014, 10 (12) 5116-5127 10.1016/j.actbio.2014.08.021
19. Agashe, H. B.; Dutta, T.; Garg, M.; Jain, N. K. Investigations on the Toxicological Profile of Functionalized Fifth-generation Poly(propylene imine) Dendrimer J. Pharm. Pharmacol. 2006, 58, 1491-1498 10.1211/jpp.58.11.0010
20. Mayer, A.; Vadon, M.; Rinner, B.; Novak, A.; Wintersteiger, R.; Frohlich, E. The Role of Nanoparticle Size in Hemocompatibility Toxicology 2009, 258 (2-3) 139-147 10.1016/j.tox.2009.01.015
21. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review J. Controlled Release 2000, 65 (1-2) 271-284 10.1016/S0168-3659(99)00248-5
22. Choi, J. Y.; Ramasamy, T.; Tran, T. H.; Ku, S. K.; Shin, B. S.; Choi, H. G.; Yong, C. S.; Kim, J. O. Systemic Delivery of Axitinib with Nanohybrid Liposomal Nanoparticles Inhibits Hypoxic Tumor Growth J. Mater. Chem. B 2015, 3, 408-416 10.1039/C4TB01442A
23. Garg, G.; Saraf, S.; Saraf, S. Cubosomes: An Overview Biol. Pharm. Bull. 2007, 30 (2) 350-353 10.1248/bpb.30.350
24. Spicer, P. T.; Hayden, K. L.; Lynch, M. L.; Ofori-Boateng, A.; Burns, J. L. Novel Process for Producing Cubic Liquid Crystalline Nanoparticles (Cubosomes) Langmuir 2001, 17 (19) 5748-5756 10.1021/la010161w
25. Yoon, H. J.; Lim, T. G.; Kim, J. H.; Cho, Y. M.; Kim, Y. S.; Chung, U. S.; Kim, J. H.; Choi, B. W.; Koh, W. G.; Jang, W. D. Fabrication of Multifunctional Layer-by-Layer Nanocapsules Toward the Design of Theragnostic Nanoplatform Biomacromolecules 2014, 15 (4) 1382-1389 10.1021/bm401928f
26. Bei, D.; Zhang, T.; Murowchick, J. B.; Youan, B. B. Formulation of Dacarbazine-loaded Cubosomes. Part III. Physicochemical Characterization AAPS PharmSciTech 2010, 11 (3) 1243-1249 10.1208/s12249-010-9496-7
27. Zhang, H.; Zhang, F. M.; Yan, S. J. Preparation, In vitro Release, and Pharmacokinetics in Rabbits of Lyophilized Injection of Sorafenib Solid Lipid Nanoparticles Int. J. Nanomed. 2012, 7, 2901-2910 10.2147/IJN.S32415
28. Ramasamy, T.; Tran, T. H.; Cho, H. J.; Kim, J. H.; Kim, Y. I.; Jeon, J. Y.; Choi, H. G.; Yong, C. S.; Kim, J. O. Chitosan-based Polyelectrolyte Complexes as Potential Nanoparticulate Carriers: Physicochemical and Biological Characterization Pharm. Res. 2014, 31 (5) 1302-1314 10.1007/s11095-013-1251-9
29. Kato, Y.; Ozawa, S.; Miyamoto, C.; Maehata, Y.; Suzuki, A.; Maeda, T.; Baba, Y. Acidic Extracellular Microenvironment and Cancer Cancer Cell Int. 2013, 13, 89 (8 pp). 10.1186/1475-2867-13-89
30. Huang, W. C.; Hsieh, Y. L.; Hung, C. M.; Chien, P. H.; Chien, Y. F.; Chen, L. C.; Tu, C. Y.; Chen, C. H.; Hsu, S. C.; Lin, Y. M.; Chen, Y. J. BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib PLoS One 2013, 8 (12) e83627 10.1371/journal.pone.0083627
31. Feng, S. T.; Li, J.; Luo, Y.; Yin, T.; Cai, H.; Wang, Y.; Dong, Z.; Shuai, X.; Li, Z. P. pH-sensitive Nanomicelles for Controlled and Efficient Drug Delivery to Human Colorectal Carcinoma LoVo Cells PLoS One 2014, 9 (6) e100732 10.1371/journal.pone.0100732